Journal of Clinical Endocrinology & Metabolism, Vol 55, 276-283, Copyright © 1982 by Endocrine Society

ARTICLES

Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D)

D Chalbos, F Vignon, I Keydar and H Rochefort

The effects of estradiol (E2) on two cloned sublines derived from the T47D human breast cancer cell line have been studied in vitro. Cell proliferation was evaluated by DNA assay, cell counts, and thymidine incorporation. The rate of synthesis of proteins released into the cell culture medium was assayed by [35S]methionine incorporation and polyacrylamide gel electrophoresis, followed by fluorography. In clone 11, which contains estrogen and progesterone receptors, estradiol (1 pM- 1 nM) stimulated cell proliferation 2- to 5-fold after a lag period of 6 days. Maximal stimulation was observed with 1% or 3% fetal calf serum and without added insulin. The effect of E2 was biphasic, since the growth rate was stimulated for E2 concentrations less than 10 nM and then progressively inhibited for higher concentrations. Dexamethasone, dihydrotestosterone, progesterone, and R5020 (at 1 nM or 1 microM) did not modify cell growth. The antiestrogen Tamoxifen (1 microM) inhibited the E2-induced stimulation and decreased the growth of control cells. Estrogen also stimulated 2- to 3-fold the synthesis of approximately 60K molecular weight dalton proteins which were released into the medium. This effect was seen as early as 1 day of E2 treatment, and a plateau of stimulation was reached with 0.1 nM E2. By contrast, in clone 8, which contains low concentrations of estrogen and progesterone receptors, E2 had no effect on cell growth and stimulated slightly the synthesis of a 55K protein. These results demonstrate that E2 is able to directly stimulate the proliferation of human epithelial breast cancer cells after having stimulated the synthesis of approximately 60,000 dalton proteins released into the medium.

This article has been cited by other articles:

				J. M. Dixon, L. Renshaw, O. Young, J. Murray, E. J. Macaskill, M. McHugh, E. Folkerd, D. A. Cameron, R. P. A'Hern, and M. Dowsett Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer J. Clin. Oncol., April 1, 2008; 26(10): 1671 - 1676. [Abstract] [Full Text] [PDF]

				K. A. Bolanz, M. A. Hediger, and C. P. Landowski The role of TRPV6 in breast carcinogenesis Mol. Cancer Ther., February 1, 2008; 7(2): 271 - 279. [Abstract] [Full Text] [PDF]

				J. L. Kipp, S. M. Kilen, S. Bristol-Gould, T. K. Woodruff, and K. E. Mayo Neonatal Exposure to Estrogens Suppresses Activin Expression and Signaling in the Mouse Ovary Endocrinology, May 1, 2007; 148(5): 1968 - 1976. [Abstract] [Full Text] [PDF]

				K. B. Bouker, T. C. Skaar, D. R. Fernandez, K. A. O'Brien, R. B. Riggins, D. Cao, and R. Clarke Interferon Regulatory Factor-1 Mediates the Proapoptotic but Not Cell Cycle Arrest Effects of the Steroidal Antiestrogen ICI 182,780 (Faslodex, Fulvestrant) Cancer Res., June 1, 2004; 64(11): 4030 - 4039. [Abstract] [Full Text] [PDF]

				M. G. Ghosh, D. A. Thompson, and R. J. Weigel PDZK1 and GREB1 Are Estrogen-regulated Genes Expressed in Hormone-responsive Breast Cancer1, 2 Cancer Res., November 1, 2000; 60(22): 6367 - 6375. [Abstract] [Full Text]

				W. Xie, R. Duan, I. Chen, I. Samudio, and S. Safe Transcriptional Activation of Thymidylate Synthase by 17{beta}-Estradiol in MCF-7 Human Breast Cancer Cells Endocrinology, July 1, 2000; 141(7): 2439 - 2449. [Abstract] [Full Text] [PDF]

				G. Luboshits, S. Shina, O. Kaplan, S. Engelberg, D. Nass, B. Lifshitz-Mercer, S. Chaitchik, I. Keydar, and A. Ben-Baruch Elevated Expression of the CC Chemokine Regulated on Activation, Normal T Cell Expressed and Secreted (RANTES) in Advanced Breast Carcinoma Cancer Res., September 1, 1999; 59(18): 4681 - 4687. [Abstract] [Full Text] [PDF]

				A. Philips, C. Teyssier, F. Galtier, C. Rivier-Covas, J.-M. Rey, H. Rochefort, and D. Chalbos FRA-1 Expression Level Modulates Regulation of Activator Protein-1 Activity by Estradiol in Breast Cancer Cells Mol. Endocrinol., July 1, 1998; 12(7): 973 - 985. [Abstract] [Full Text]